https://www.pharmanow.live/latest-news/cronus-pharma-fda-approved-generic-robenacoxib-injection-veterinary 2026-08-27T21:55:26+05:30 Pharma Now en 2026-08-27T00:00:00+05:30 Cronus Pharma Wins FDA Nod for Generic Robenacoxib Injection Cronus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/e1816447-701a-4a89-b876-ba65c6313cbe.png https://www.pharmanow.live/latest-news/propanc-biopharma-prp-preclinical-pdac-tumor-growth-inhibition 2026-08-27T22:07:10+05:30 Pharma Now en 2026-08-27T00:00:00+05:30 Propanc Reports Over 90% Tumor Inhibition for PRP Propanc https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/a2d48b7a-a99d-4f3e-990b-8af21728309b.png https://www.pharmanow.live/latest-news/verrica-pharmaceuticals-cove-2-enrollment-complete-ycanth-common-warts-phase-3 2026-08-27T21:50:10+05:30 Pharma Now en 2026-08-27T00:00:00+05:30 Verrica Completes COVE-2 Enrollment for YCANTH Verrica https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/722fa2d3-9375-4ff9-b323-cbae2fd73544.png https://www.pharmanow.live/latest-news/abbott-gains-ce-mark-amulet-360-laa-occluder-atrial-fibrillation 2026-08-27T21:54:16+05:30 Pharma Now en 2026-08-27T00:00:00+05:30 Abbott Wins CE Mark for Amulet 360 LAA Occluder Abbott https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://mma.prnewswire.com/media/2761216/Abbott_New_Logo.jpg?p=thumbnail https://www.pharmanow.live/latest-news/cormica-compounding-enforcement-roadmap-503a-503b-inspection-deficiencies 2026-08-27T22:01:06+05:30 Pharma Now en 2026-08-27T00:00:00+05:30 Cormica Publishes FDA Compounding Enforcement Roadmap Cormica https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.cormica.com/wp-content/uploads/2026/08/pharmaceutical-cleanroom-image.png https://www.pharmanow.live/latest-news/sanofi-fda-updated-approval-tenivac-td-vaccine-august-2026 2026-08-27T21:57:04+05:30 Pharma Now en 2026-08-27T00:00:00+05:30 Sanofi Gains Updated FDA Approval for TENIVAC Vaccine Sanofi https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/24fe4e02-fbb6-4f64-b1a2-5f1095b4d548.png https://www.pharmanow.live/latest-news/moleculin-miracle-trial-phase-2-3-aml-enrollment-milestone 2026-08-27T22:05:03+05:30 Pharma Now en 2026-08-27T00:00:00+05:30 Moleculin Hits Enrollment Milestone in Relapsed AML Trial Moleculin https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/ac46bc10-b3d5-4fa0-8a7a-a4f8cc0ed0d7.png https://www.pharmanow.live/latest-news/nicox-secures-april-2027-pdufa-date-ncx-470-glaucoma-nda 2026-08-27T14:12:46+05:30 Pharma Now en 2026-08-27T00:00:00+05:30 Nicox Secures April 2027 PDUFA Date for NCX 470 Glaucoma Drug NDA Nicox https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/89f67468-876a-4ab4-acdc-7d3679a793db/8b7e0483-56a0-414c-b549-cf109f43c89c.png https://www.pharmanow.live/latest-news/abbvie-ema-submission-risankizumab-subcutaneous-induction-crohns-disease 2026-08-27T14:09:54+05:30 Pharma Now en 2026-08-27T00:00:00+05:30 AbbVie Submit EMA Application for Risankizumab in Crohn’s Disease AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/89f67468-876a-4ab4-acdc-7d3679a793db/bb884e2e-78b5-412c-a5bc-5a7d975c3898.png https://www.pharmanow.live/latest-news/revolution-medicines-fda-approval-daraxonrasib-metastatic-pancreatic-adenocarcinoma 2026-08-27T14:09:58+05:30 Pharma Now en 2026-08-27T00:00:00+05:30 Revolution Medicines Wins FDA Approval for Daraxonrasib in mPDAC Revolution Medicines https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e05d6b50-0a18-4510-b500-c4b2cf08f0ac/aed6f2ac-fbf1-459e-b9df-9f130270dda1.png https://www.pharmanow.live/latest-news/priovant-therapeutics-valor-trial-brepocitinib-dermatomyositis-skin-outcomes 2026-08-26T22:05:53+05:30 Pharma Now en 2026-08-26T00:00:00+05:30 Priovant Publishes Phase 3 Brepocitinib Skin Outcomes Priovant https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/73d7ff2c-b2ad-4820-aad5-c53bd1e0d041/ccb90d18-fbe0-46b5-857f-be599c7da8e6.png https://www.pharmanow.live/latest-news/revolution-medicines-fda-approval-daraxonrasib-metastatic-pancreatic-adenocarcinoma 2026-08-26T22:04:39+05:30 Pharma Now en 2026-08-26T00:00:00+05:30 Revolution Medicines Wins FDA Approval for Daraxonrasib Revolution https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/73d7ff2c-b2ad-4820-aad5-c53bd1e0d041/13520b3a-ddfc-455a-8037-3d86427980f9.png https://www.pharmanow.live/latest-news/baxter-recalls-sodium-chloride-injection-fiberglass-particulate-contamination-2026 2026-08-26T22:02:26+05:30 Pharma Now en 2026-08-26T00:00:00+05:30 Baxter Recalls Two Sodium Chloride Lots Over Fiberglass Baxter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/73d7ff2c-b2ad-4820-aad5-c53bd1e0d041/76148d95-c103-4dae-bd59-d0f874f76f83.png https://www.pharmanow.live/latest-news/aurigene-signs-long-term-manufacturing-deal-20-plus-drug-products-global-markets 2026-08-26T13:47:18+05:30 Pharma Now en 2026-08-26T00:00:00+05:30 Aurigene Signs Long-Term Deal Covering 20+ Drug Products Globally Aurigene https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a57601d2-be80-46af-bc7d-c6419a66bd0c/4e216049-0fb9-4ddd-a0d7-b3eadcb21bdb.png https://www.pharmanow.live/latest-news/cipla-pithampur-facility-seven-observation-form-483-usfda-follow-up-inspection 2026-08-26T13:52:14+05:30 Pharma Now en 2026-08-26T00:00:00+05:30 Cipla Pithampur Facility Gets 7-Observation Form 483 From USFDA Cipla https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a57601d2-be80-46af-bc7d-c6419a66bd0c/0f9b4b57-ac67-4737-aa3d-7f2e7502eec1.png https://www.pharmanow.live/latest-news/ascendis-pharma-week-104-approch-trial-yuviwel-isds-2026 2026-08-26T13:47:04+05:30 Pharma Now en 2026-08-26T00:00:00+05:30 Ascendis Presents Week 104 Approach Trial Data for YUVIWEL Ascendis https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/35497d58-26dd-4886-8738-41454359bee3/4d0b87ab-9e96-4b29-8ac0-ccfa3f05e171.png https://www.pharmanow.live/latest-news/fda-approves-tivicay-pd-oral-suspension-hiv-neonates 2026-08-26T13:52:15+05:30 Pharma Now en 2026-08-26T00:00:00+05:30 FDA Approves Tivicay PD for HIV Treatment in Newborns FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/35497d58-26dd-4886-8738-41454359bee3/1d3e780c-8260-4a72-99b5-d0492b1e6b93.png https://www.pharmanow.live/latest-news/fda-accelerated-approval-tracker-benznidazole-hepcludex-pmr-deadlines 2026-08-26T13:52:15+05:30 Pharma Now en 2026-08-26T00:00:00+05:30 FDA Tracker Flags Benznidazole PMR, Hepcludex Faces 2034 Deadline FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/35497d58-26dd-4886-8738-41454359bee3/9368ee86-7984-457c-a13f-2e69cda8c3e0.png https://www.pharmanow.live/latest-news/fda-wap-sensual-enhancement-undeclared-api-adulteration-2026 2026-08-26T13:47:09+05:30 Pharma Now en 2026-08-26T00:00:00+05:30 FDA Confirm WAP Sensual Enhancement Has Four Undeclared Drugs Key FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/35497d58-26dd-4886-8738-41454359bee3/9b92c49f-cdd7-47ce-9a4f-bf5e054f1615.png https://www.pharmanow.live/latest-news/baxter-recalls-70-percent-dextrose-injection-stainless-steel-particulate-contamination 2026-08-26T13:47:06+05:30 Pharma Now en 2026-08-26T00:00:00+05:30 Baxter Recalls Dextrose Injection Lot Over Steel Contamination Baxter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/35497d58-26dd-4886-8738-41454359bee3/7fd91d3a-3e7c-47d0-be71-0dba57d0e57b.png